Open letter to everyone served by The Shrewsbury and Telford Hospital NHS Trust

14 April 2022 Below is an open letter from Chief Executive, Louise Barnett. This letter can also be read here. An open letter to everyone served by The Shrewsbury and Telford Hospital NHS Trust On Wednesday 30 March 2022, Mrs Donna Ockenden published her final report of the Independent Review of Maternity Services at our hospitals. The report is devastating [...]

Open letter to everyone served by The Shrewsbury and Telford Hospital NHS Trust2022-04-14T17:12:00+01:00

Fertility Services lead appointed to national board

17 February 2021 The Head of Fertility Services at the Trust that runs Shropshire’s two acute hospitals has been appointed by the Government to the board of the Human Fertilisation and Embryology Authority (HFEA). Jason Kasraie As a member of the HFEA, , the body that governs and regulates assisted conception treatment and human gamete and embryo research, [...]

Fertility Services lead appointed to national board2021-02-17T10:37:01+00:00

Open letter to the people served by The Shrewsbury and Telford Hospital NHS Trust

21 July 2020 An independent review, led by experienced midwife Donna Ockenden, is looking into maternity cases involving families from our communities. Today, we know that the total number of families whose cases are being reviewed is 1,862. We recognise that this will be concerning, both for those families and everyone in our communities, who depend on us for their [...]

Open letter to the people served by The Shrewsbury and Telford Hospital NHS Trust2020-07-21T09:43:23+01:00

Coronavirus: SaTH plays key role in dexamethasone trial

17 June 2020 Patients and staff at The Shrewsbury and Telford Hospital NHS Trust (SaTH) have played a key role in the trial of a drug which has been shown to reduce deaths amongst patients with severe respiratory complications caused by coronavirus. Helen Moore The Research & Innovation and Critical Care teams at SaTH, which runs the Princess [...]

Coronavirus: SaTH plays key role in dexamethasone trial2020-06-17T12:50:57+01:00